Organic sodium salts
Selleck Chemical LLC CNQX-E0484-25MG
CNQX (6-cyano-7-nitroquinoxaline-2 3-dione) is an AMPA and kainate receptor antagonist with IC50 values are 0 3 M and 1 5 M for AMPA and kainate receptors respectively CNQX is also an antagonist at the glycine modulatory site on the NMDA receptor complex (IC50 25 M) CNQX shows neuroprotective effects in models of ischemia and inhibits seizure-like activity in hippocampal neurons
TARGETMOL CHEMICALS INC NBQX 10MG
Also available in 1 mg 5 mg 25 mg 50 mg 100 mg 200 mg 1 mL 10 mM (in DMSO) and bulk. Please contact Fisher for quotes. NBQX (FG9202) is a potent selective and competitive AMPA receptor antagonist. Neuroprotective and anticonvulsant; active in vivo. purity: 99%
Chemscene ChemScene | Sodium methanesulfinate | 500G | CS-0019422 | 0.97 | 20277-69-4| MFCD00040392 | 102.09
ChemScene | Sodium methanesulfinate | 500G | CS-0019422 | 0.97 | 20277-69-4| MFCD00040392 | 102.09
FUJIFILM Biosciences SODIUM OXAMATE 5 G
*Orders for this supplier are non-cancellable/non-returnable once they are processed.* Sodium Oxamate 5 G. 565-73-1 MFCD00044553
Medchemexpress LLC Benzo[f]quinoxaline-7-sulfonamide, 1,2,3,4-tetrahydro-6-nitro-2,3-dioxo-, sodium salt (1:2) | 479347-86-9 | C12H6N4Na2O6S | 25 MG
NBQX disodium is a highly selective and competitive antagonist of the AMPA receptor, exhibiting neuroprotective and anticonvulsant activity. It possesses a high affinity for AMPA and kainate binding sites, with minimal affinity for the glutamate recognition site on the NMDA receptor complex.
- Highly selective and competitive AMPA receptor antagonist
- Exhibits neuroprotective activity
- Shows anticonvulsant activity
- High affinity for AMPA and kainate binding sites
- Little to no affinity for the NMDA receptor complex
Medchemexpress LLC NBQX | 118876-58-7 | 99.8% | 336.28 | 10 MG
NBQX (FG9202) is a highly selective and competitive AMPA receptor antagonist. It possesses neuroprotective and anticonvulsant activity.
- Highly selective and competitive AMPA receptor antagonist.
- Exhibits neuroprotective activity.
- Has anticonvulsant activity.
- Decreases seizures.
- Neuroprotective in a focal ischaemia model.
- Has high affinity for AMPA and kainate binding sites.
- Shows little to no affinity for the glutamate recognition site on the NMDA receptor complex.
Medchemexpress LLC CNQX disodium | 479347-85-8 | C9H2N4Na2O4 | 25 MG
CNQX disodium is a potent and competitive antagonist for AMPA/kainate receptors, with IC50s of 0.3 μM and 1.5 μM respectively. It also acts as a competitive non-NMDA receptor antagonist and has been shown to block the expression of fear-potentiated startle in rats.
- Potent and competitive AMPA/kainate receptor antagonist
- IC50 values of 0.3 μM for AMPA and 1.5 μM for kainate receptors
- Competitive non-NMDA receptor antagonist
- Demonstrated activity in in vitro studies, including reversible blockade of Schaffer collateral and mossy fibre excitatory postsynaptic potential (EPSP)
- Demonstrated activity in in vivo studies, showing decreased cocaine responses and partial blockade of stepdown inhibitory avoidance
Medchemexpress LLC CNQX disodium | 479347-85-8 | C9H2N4Na2O4 | 5 MG
CNQX disodium (FG9065 disodium) is a potent and competitive AMPA/kainate receptor antagonist. It blocks the expression of fear-potentiated startle in rats and is a competitive non-NMDA receptor antagonist. It is suitable for in vitro and in vivo research.
- Potent and competitive AMPA/kainate receptor antagonist
- Blocks expression of fear-potentiated startle
- Competitive non-NMDA receptor antagonist
- Suitable for neurological disease research
- Inhibitor of ionotropic glutamate receptors
Pfaltz & Bauer Dimethyldithiocarbamic acid s 100G | 128-04-1
Dimethyldithiocarbamic acid s 100G | 128-04-1
